Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.

Pestana, J O Medina; Grinyo, J M; Vanrenterghem, Y; Becker, T; Campistol, J M; Florman, S; Garcia, V D; Kamar, N; Lang, P; Manfro, R C; Massari, P; Rial, M D C; Schnitzler, M A; Vitko, S; Duan, T; Block, A; Harler, M B; Durrbach, A

Pestana, J O Medina; Grinyo, J M; Vanrenterghem, Y; Becker, T; Campistol, J M; Florman, S; Garcia, V D; Kamar, N; Lang, P; Manfro, R C; Massari, P; Rial, M D C; Schnitzler, M A; Vitko, S; Duan, T; Block, A; Harler, M B; Durrbach, A.

Affiliation

Pestana JO; Department of Medicine, Division of Nephrology, Hospital do Rim e Hipertensão, University of Sao Paulo, Brazil.

Am J Transplant ; 12(3): 630-9, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22300431

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Kidney Transplantation / Immunoconjugates / Graft Rejection / Immunosuppressive Agents / Kidney Failure, Chronic Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2012 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google